Straumann Holding AG Current Ratio 2012-2025 | SAUHY
Current and historical current ratio for Straumann Holding AG (SAUHY) from 2012 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Straumann Holding AG current ratio for the three months ending December 31, 2025 was 0.00.
| Straumann Holding AG Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-12-31 | $1.99B | $0.90B | 2.21 |
| 2025-06-30 | $1.78B | $1.08B | 1.64 |
| 2024-12-31 | $1.73B | $1.07B | 1.61 |
| 2024-06-30 | $1.69B | $0.80B | 2.11 |
| 2023-12-31 | $1.55B | $0.80B | 1.95 |
| 2022-12-31 | $1.67B | $1.02B | 1.64 |
| 2021-12-31 | $1.67B | $0.62B | 2.72 |
| 2021-06-30 | $1.50B | $0.51B | 2.95 |
| 2020-12-31 | $1.23B | $0.41B | 3.04 |
| 2020-06-30 | $0.96B | $0.45B | 2.15 |
| 2019-12-31 | $0.89B | $0.58B | 1.52 |
| 2018-12-31 | $0.78B | $0.28B | 2.81 |
| 2017-12-31 | $0.70B | $0.22B | 3.20 |
| 2017-06-30 | $0.51B | $0.17B | 2.97 |
| 2016-12-31 | $0.46B | $0.17B | 2.71 |
| 2016-06-30 | $0.61B | $0.17B | 3.58 |
| 2015-12-31 | $0.57B | $0.17B | 3.42 |
| 2014-12-31 | $0.73B | $0.15B | 4.83 |
| 2013-12-31 | $0.61B | $0.13B | 4.73 |
| 2013-06-30 | $0.55B | $0.11B | 4.88 |
| 2012-12-31 | $0.34B | $0.11B | 2.96 |
| 2012-06-30 | $0.34B | $0.15B | 2.33 |
| 2011-12-31 | $0.63B | $0.13B | 5.01 |
| 2008-12-31 | $0.33B | $0.15B | 2.20 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $16.902B | $3.144B |
| The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |